Vir Biotechnology Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.6 | 2.8 | 3.1 | 2.3 | 6.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 877.2 | 529.5 | 64.4 | 59.0 | 47.1 | 97.3 | 35.5 | 20.7 | 5.1 | 1.5 | 1.6 | 1.1 | 2.1 | 7.0 | 6.7 | 10.6 | 15.8 | 17.2 | 15.4 | 13.0 | 13.5 | 42.8 | 36.4 | 47.0 | 12.2 | 20.2 | 5.7 | |
| – | – | – | – | – | – | – | 2.7 | 9.8 | 8.4 | 5.3 | 4.8 | 10.1 | 8.6 | 6.6 | 3.9 | 1.7 | 1.7 | 1.2 | 1.6 | 1.6 | 1.8 | 0.8 | 0.9 | 0.9 | 0.8 | 0.8 | 0.9 | 0.9 | 0.7 | 1.0 | 1.1 | 1.6 | 1.8 | |
| – | – | – | – | – | – | – | 794.6 | 506.0 | 59.4 | 52.7 | 41.1 | 89.6 | 31.4 | 18.2 | 4.8 | 1.1 | 0.9 | 0.7 | 1.6 | 5.1 | 5.4 | 6.9 | 13.1 | 15.3 | 11.9 | 11.1 | 10.6 | 30.1 | 25.8 | 37.4 | 8.9 | 16.2 | 4.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.3 | 1.5 | 1.3 | 1.1 | 3.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.2 | 2.5 | 1.7 | 2.1 | 3.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -12.0% | -4.2% | -3.0% | -3.6% | -5.8% | -3.6% | -1.4% | -2.6% | -1.2% | 16.1% | 40.2% | 60.2% | 47.4% | 29.8% | -12.5% | -52.9% | -58.9% | -57.0% | -37.8% | -46.2% | -45.4% | -47.2% | -67.4% | -58.1% | -46.9% | -33.5% | -19.2% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | -1,994.4% | -4,066.6% | -48,930.0% | -34,398.0% | -11,209.8% | -2,481.3% | -106.9% | -52.5% | 20.2% | 100.0% | 51.0% | 31.2% | 65.4% | 76.0% | 70.8% | 72.9% | 61.6% | -34.5% | -27.4% | -433.6% | -572.0% | -550.9% | -477.0% | -542.7% | -557.3% | -2,329.4% | -2,527.1% | -2,600.9% | 100.0% | 275.2% | 170.0% | |
| – | – | – | -2,442.2% | -4,853.9% | -57,256.1% | -40,755.8% | -13,483.2% | -3,120.9% | -290.1% | -344.9% | -409.8% | -569.6% | -164.8% | -92.1% | 38.5% | 68.5% | 62.0% | 65.4% | 51.6% | -72.6% | -64.0% | -585.7% | -794.0% | -780.2% | -715.6% | -774.7% | -791.3% | -3,099.7% | -3,191.7% | -3,253.6% | -682.7% | -704.9% | -89.0% | |
| – | – | – | -2,425.9% | -4,726.7% | -54,909.0% | -39,683.5% | -13,233.6% | -3,179.8% | -301.2% | -351.0% | -412.1% | -579.5% | -166.9% | -36.3% | 48.3% | 52.3% | 51.1% | 48.0% | 31.9% | -32.2% | -53.4% | -505.6% | -713.7% | -677.7% | -612.4% | -678.4% | -703.4% | -2,769.0% | -2,895.9% | -2,963.5% | -638.9% | -676.0% | -83.0% | |
| – | – | – | -2,177.7% | -4,834.7% | -57,560.1% | -37,700.6% | -10,497.9% | -2,212.2% | -191.7% | -209.8% | -272.5% | -353.3% | -49.4% | -52.7% | -6.3% | 23.9% | 64.3% | 65.9% | 98.7% | 208.0% | -83.5% | -562.6% | -928.7% | -978.6% | -581.6% | -601.7% | -611.4% | -2,023.6% | -2,454.6% | -2,730.9% | -571.5% | -679.2% | -109.3% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | -89.0% | -30.5% | – | -41.2% | -58.7% | -39.1% | -31.6% | -41.7% | -60.0% | -40.3% | -11.7% | 36.9% | 60.8% | 55.2% | 53.2% | 24.8% | -7.3% | -14.5% | -35.9% | -38.7% | -34.9% | -33.7% | -43.0% | -45.4% | -55.3% | -58.1% | -62.8% | -57.2% | -54.5% | -25.6% | |
| – | – | – | -60.5% | -25.5% | -26.8% | -32.5% | -34.1% | -46.8% | -32.8% | -27.2% | -32.5% | -34.4% | -28.1% | -8.5% | 27.0% | 42.1% | 41.2% | 42.4% | 18.4% | -5.4% | -11.7% | -29.4% | -32.1% | -30.1% | -28.9% | -35.6% | -37.3% | -44.2% | -46.1% | -49.0% | -43.7% | -43.2% | -20.7% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| 188 | – | – | -33 | 98 | -62 | -71 | -109 | -165 | -368 | -459 | -433 | -518 | -738 | -711 | -344 | -808 | -1,501 | -960 | -844 | -818 | -653 | -439 | -229 | -149 | -277 | -149 | -215 | -266 | -202 | -161 | -225 | -267 | -270 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.5 | -0.5 | -1.1 | -0.6 | -1.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -93.5% | 28.7% | 87.9% | -66.4% | 82.8% | 79.7% | 83.9% | 86.1% | 78.0% | 57.3% | 69.7% | 72.4% | 73.3% | 69.3% | 74.5% | 79.7% | 74.2% | 73.9% | 80.7% | 81.9% | 82.9% | 86.3% | 85.9% | 82.8% | 82.2% | 79.8% | 79.5% | 78.1% | 76.3% | 79.2% | 80.9% | |
| 0.0 | – | – | – | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -1.20 | -1.20 | -1.12 | -1.26 | -1.90 | -2.06 | -1.92 | -2.04 | -2.35 | -3.06 | -2.22 | -0.76 | 3.95 | 9.04 | 8.14 | 8.47 | 3.87 | -1.08 | -1.95 | -4.47 | -4.57 | -3.99 | -3.55 | -3.90 | -3.82 | -4.20 | -3.97 | -3.60 | -3.15 | -3.00 | -1.49 | |
| – | – | – | 0.05 | 0.03 | 0.00 | 0.00 | 0.01 | 0.06 | 0.64 | 0.58 | 0.57 | 0.53 | 1.33 | 2.10 | 8.17 | 17.29 | 15.92 | 17.63 | 12.13 | 3.34 | 3.66 | 0.88 | 0.64 | 0.59 | 0.58 | 0.58 | 0.54 | 0.15 | 0.14 | 0.12 | 0.49 | 0.44 | 1.80 | |
| 32.20 | – | – | -1.85 | 1.35 | 3.67 | -2.57 | 4.61 | 3.51 | 4.90 | 6.46 | 5.63 | 5.10 | 5.51 | 6.55 | 10.70 | 14.87 | 14.74 | 15.93 | 15.61 | 14.76 | 13.50 | 12.47 | 11.81 | 11.44 | 10.52 | 9.08 | 8.41 | 7.59 | 6.84 | 5.73 | 5.50 | 5.52 | 5.82 | |
| – | – | – | -1.07 | -1.23 | -1.17 | -1.19 | -1.51 | -1.43 | -1.22 | -1.22 | -1.55 | -1.86 | -0.66 | -1.11 | -0.52 | 4.13 | 10.24 | 11.61 | 11.98 | 6.95 | -3.06 | -4.98 | -5.95 | -5.76 | -3.37 | -3.46 | -3.32 | -3.07 | -3.37 | -3.31 | -2.81 | -3.02 | -1.96 | |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.